Robust design and operation of quasi-continuous adenovirus purification by two-column, simulated moving-bed, size-exclusion chromatography by Mota, Jose et al.
Engineering Conferences International
ECI Digital Archives
Integrated Continuous Biomanufacturing II Proceedings
Fall 11-2-2015
Robust design and operation of quasi-continuous
adenovirus purification by two-column, simulated
moving-bed, size-exclusion chromatography
Jose Mota
IBET & FCT-UNL, Portugal
Ricardo Silva
IBET, Portugal
Piergiuseppe Nestolla
IBET, Portugal
Cristina Peixoto
IBET, Portugal
Manuel Carrondo
IBET, Portugal
Follow this and additional works at: http://dc.engconfintl.org/biomanufact_ii
Part of the Biomedical Engineering and Bioengineering Commons
This Conference Proceeding is brought to you for free and open access by the Proceedings at ECI Digital Archives. It has been accepted for inclusion in
Integrated Continuous Biomanufacturing II by an authorized administrator of ECI Digital Archives. For more information, please contact
franco@bepress.com.
Recommended Citation
Jose Mota, Ricardo Silva, Piergiuseppe Nestolla, Cristina Peixoto, and Manuel Carrondo, "Robust design and operation of quasi-
continuous adenovirus purification by two-column, simulated moving-bed, size-exclusion chromatography" in "Integrated Continuous
Biomanufacturing II", Chetan Goudar, Amgen Inc. Suzanne Farid, University College London Christopher Hwang, Genzyme-Sanofi
Karol Lacki, Novo Nordisk Eds, ECI Symposium Series, (2015). http://dc.engconfintl.org/biomanufact_ii/67
ROBUST DESIGN AND OPERATION OF QUASI-CONTINUOUS ADENOVIRUS PURIFICATION BY TWO-
COLUMN, SIMULATED MOVING-BED, SIZE-EXCLUSION CHROMATOGRAPHY 
 
José P. Mota, IBET & FCT-UNL, Portugal 
Ricardo Silva, IBET, Portugal 
Piergiuseppe Nestola, IBET, Portugal 
Cristina Peixoto, IBET Portugal 
Manuel Carrondo, IBET, Portugal 
 
 
Key Words: Virus purification, multicolumn chromatography, simulated moving bed, size-exclusion chromatog-
raphy. 
 
Adenoviruses (Ads) are considered one of the most suitable platforms for production of viral vaccines and gene 
therapy vectors.  Their broad tissue tropism and large transgene packing capacity make them attractive candi-
dates for innovative virotherapies.  Ads can be produced in a complementary cell line in both adherent and 
suspension culture systems, such as HEK-293 or PER-C6 cells, or A549 for oncolytic therapies.  
Liquid chromatography is currently the core technique for vector purification, and its use is often integrated 
vertically within the downstream processing (DSP) strategy, as it easily fits into the early capture stage as well 
as into the final purification phase.  The use of high-performance liquid chromatography (HPLC) for large-scale 
adenoviral purification is an already established method, including ion exchange (IEX), size exclusion (SEC), hy-
drophobic interaction, and immobilized metal affinity chromatography.  Unlike traditional processes based on 
CsCl-gradient purification, HPLC offers a straightforward linear scale-up path, and procedures for purifying up to 
around 1014 input particles have been reported.  SEC and ultra/diafiltration (usually by tangential flow filtration) 
are two other widely used processes at the very latest stage for formulating the product. 
One process-based way to improve the performance of the DSP chromatographic steps is by changing to a (quasi-
)continuous processing mode, which, in principle, yields higher throughput, lower buffer consumption, higher 
capacity utilization of the stationary phase and reduced column volume, hence increased productivity. 
In this work, a simple, yet efficient, two-column simulated moving-bed (2CSMB) process for purifying adenovirus 
serotype 5 (Ad5) by size-exclusion chromatography (SEC) is presented and validated experimentally, and a gen-
eral procedure for its robust design and operation under parameter uncertainty is described. The pilot-scale run 
yielded a virus recovery of 86% and DNA and HCP clearances of 90% and 89%, respectively, without any fine-
tuning of the operating parameters. This performance compares very favorably against that of single-column 
batch chromatography for the same volume of size-exclusion resin. 
To improve the robustness of the 2CSMB-SEC process, a general procedure for its design under parameter un-
certainty is proposed under the framework of rigorous optimization theory. The optimal values of the operating 
variables are chosen only among candidates that are robust feasible, that is, that remain feasible for all possible 
variations of the uncertain parameters within their uncertainty intervals. In practice the nominal design problem 
is replaced by a worst-case design problem. 
The procedure was successfully employed to find the optimal robust values of the step durations when both the 
interparticle porosity and column volume are subject to two types of uncertainties. In one case the parameters 
are uncorrelated, uniformly distributed random variables, whereas in the other case they are normally distrib-
uted random variables. Moreover, in the second case the 2CSMB-SEC operating conditions were optimized to 
yield a given probability of success of satisfying both product quality specifications, say 95%, so that on average 
at least 95 out of 100 attempts to pack the two columns yield purified batches in which the product is within the 
specifications—this is achieved while maximizing the feed throughput. 
